An official European respiratory society statement on physical activity in COPD

H. Watz, F. Pitta, C.L. Rochester, J. Garcia-Aymerich, R. ZuWallack, T. Troosters, A.W. Vaes, M.A. Puhan, M. Jehn, M.I. Polkey, I. Vogiatzis, E.M. Clini, M. Toth, E. Gimeno-Santos, B. Waschki, C. Esteban, M. Hayot, R. Casaburi, J. Porszasz, E. McAuleySally J. Singh, D. Langer, E.F.M. Wouters, H. Magnussen, M.A. Spruit

    Research output: Contribution to journalArticle

    231 Citations (Scopus)

    Abstract

    This European Respiratory Society (ERS) statement provides a comprehensive overview on physical activity in patients with chronic obstructive pulmonary disease (COPD). A multidisciplinary Task Force of experts representing the ERS Scientific Group 01.02 ''Rehabilitation and Chronic Care'' determined the overall scope of this statement through consensus. Focused literature reviews were conducted in key topic areas and the final content of this Statement was agreed upon by all members. The current knowledge regarding physical activity in COPD is presented, including the definition of physical activity, the consequences of physical inactivity on lung function decline and COPD incidence, physical activity assessment, prevalence of physical inactivity in COPD, clinical correlates of physical activity, effects of physical inactivity on hospitalisations and mortality, and treatment strategies to improve physical activity in patients with COPD. This Task Force identified multiple major areas of research that need to be addressed further in the coming years. These include, but are not limited to, the disease-modifying potential of increased physical activity, and to further understand how improvements in exercise capacity, dyspnoea and self-efficacy following interventions may translate into increased physical activity. The Task Force recommends that this ERS statement should be reviewed periodically (e.g. every 5-8 years).
    Original languageEnglish
    Pages (from-to)1521-1537
    JournalEuropean Respiratory Journal
    Volume44
    Issue number6
    DOIs
    Publication statusPublished - 2014

    Bibliographical note

    The full text of this item is available free from the link given.

    Keywords

    • beta adrenergic receptor stimulating agent
    • bronchodilating agent
    • long acting drug
    • placebo
    • ambulatory care
    • Article
    • behavior change
    • chronic obstructive lung disease
    • clinical assessment
    • daily life activity
    • disease association
    • disease exacerbation
    • disease severity
    • feedback system
    • forced expiratory volume
    • forced vital capacity
    • health status
    • hospitalization
    • human
    • medical society
    • mortality
    • oxygen therapy
    • patient counseling
    • physical activity
    • physical inactivity
    • physical performance
    • pulmonary rehabilitation
    • questionnaire
    • self concept

    Fingerprint Dive into the research topics of 'An official European respiratory society statement on physical activity in COPD'. Together they form a unique fingerprint.

  • Cite this

    Watz, H., Pitta, F., Rochester, C. L., Garcia-Aymerich, J., ZuWallack, R., Troosters, T., ... Spruit, M. A. (2014). An official European respiratory society statement on physical activity in COPD. European Respiratory Journal, 44(6), 1521-1537. https://doi.org/10.1183/09031936.00046814